This work presents SFRP2 and SOX2 as counteracting inducers of gene expression based glioblastoma subtypes, where SFRP2 suppresses SOX2 via non-canonical WNT signaling, KLF4, PDGFRs, and AKT. The gene discussed is AKT1; the disease is glioblastoma.